Avicanna Inc saw a notable increase in its stock price, climbing by over 9% in yesterday's trading session.
Avicanna Inc (AVCN.TO) experienced a significant boost in its stock price yesterday, closing at CA$0.12, a rise of 9.52%. This upward movement reflects growing investor interest and confidence in the company's strategic initiatives.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$15.45M
52W high
$0.30
52W low
$0.10
1W change
+15.00%
Beta
0.35
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 508.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+508.7% Upside
Current Price
C$0.12
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
94.9%
Annualized
90-Day Vol
81.7%
Annualized
Trend (90d)
-35.0%
Annualized drift
90d Mean
C$0.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.11 | C$0.08 – C$0.15 |
| 60 trading days | C$0.11 | C$0.07 – C$0.17 |
| 90 trading days | C$0.10 | C$0.06 – C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should keep an eye on Avicanna's ongoing developments in the medical cannabis sector, as the stock's recent performance may indicate positive market sentiment.
Stock Price Increased by 9.52%
Avicanna's market cap now stands at approximately CA$15.45 million, reflecting increased investor confidence.
Bull case
The recent surge in Avicanna's stock likely comes from its innovative healthcare programs and potential for market expansion, especially in the growing cannabis sector. Investors are optimistic about how these initiatives could shape the company's future.
Bear case
Even with the positive movement, Avicanna's financials show a negative profit margin, which raises concerns about the sustainability of its growth. This aspect could be a red flag for investors as they weigh the company's long-term prospects.
Market Performance Overview
Advertisement
Avicanna Inc's stock performance yesterday was a standout in the TSX, with a 9.52% increase. This rise is significant given the company's current market cap of CA$15.45 million, indicating a positive shift in investor sentiment.
Strategic Developments
The surge in stock price may be linked to Avicanna's ongoing initiatives, such as the launch of the MyMedi.ca Integrated Healthcare Program. This program aims to enhance the integration of medical cannabis into healthcare, potentially driving future growth.
Financial Considerations
While the stock's performance is encouraging, it's essential to consider Avicanna's financial health. The company currently reports a negative profit margin, which could pose challenges as it seeks to expand its market presence.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
